Randomized trial of oral cyclophosphamide (C) with or without veliparib (V), an oral poly (ADP-ribose) polymerase (PARP) inhibitor, in patients with recurrent BRCA-positive ovarian, or primary peritoneal or high-grade serous ovarian carcinoma.
Shivaani Kummar
No relevant relationships to disclose
Amit M. Oza
No relevant relationships to disclose
Gini F. Fleming
No relevant relationships to disclose
Daniel Sullivan
No relevant relationships to disclose
David R. Gandara
No relevant relationships to disclose
Charles Erlichman
No relevant relationships to disclose
Miguel Angel Villalona-Calero
No relevant relationships to disclose
Robert Morgan
No relevant relationships to disclose
Alice P. Chen
No relevant relationships to disclose
Jiuping Jay Ji
No relevant relationships to disclose
Deborah Allen
No relevant relationships to disclose
Chih-Jian Lih
No relevant relationships to disclose
Seth M. Steinberg
No relevant relationships to disclose
P. Mickey Williams
No relevant relationships to disclose
Barbara A. Conley
No relevant relationships to disclose
James H. Doroshow
No relevant relationships to disclose